Thus, these injectable products pose a potentially substantial safety risk to consumers." Furthermore, beyond the potential harm expected to be caused by the skin whitening products themselves, unsafe and improper skin whitening injection practices may also cause infection, transmit diseases, and sometimes even result in severe injury
The American Medical Association recommends PCAB-accredited pharmacies, specifically when providers are choosing a compounding partner, which is one of the few instances where a major medical organization has taken a position on this
(It's been placed on the FDA's list of bulk drug substances that cannot be used in compounded medications
American journal of physiology
This also raises the question whether PARP activity in BRCA1/2-deficient tumors produces a similar metabolic phenotype via NAD + depletion and whether the use of a PARP inhibitor (e.g., olaparib) to treat these tumors 10 might restore NAD + levels and counterbalance GAPDH inhibition by other oxidative agents
See the side effects section for the full breakdown
